Avalo Therapeutics Inc
NASDAQ:AVTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avalo Therapeutics Inc
NASDAQ:AVTX
|
US |
|
U
|
Unilever PLC
XMUN:UNVB
|
UK |
|
H
|
H & M Hennes & Mauritz AB
DUS:HMSB
|
SE |
|
I
|
Interactive Brokers Group Inc
F:KY6
|
US |
|
Equinor ASA
OSE:EQNR
|
NO |
Wall St Price Targets
AVTX Price Targets Summary
Avalo Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AVTX is 46.41 USD with a low forecast of 34.34 USD and a high forecast of 63 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AVTX's stock price target?
Price Target
46.41
USD
According to Wall Street analysts, the average 1-year price target for AVTX is 46.41 USD with a low forecast of 34.34 USD and a high forecast of 63 USD.
What is the Revenue forecast for Avalo Therapeutics Inc?
Projected CAGR
227%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 8 years is 227%.
What is the Gross Profit forecast for Avalo Therapeutics Inc?
Projected CAGR
221%
The compound annual growth rate for Gross Profit over the next 8 years is 221%.
